Skip to content

Diagnostic Accuracy of a Specialized Pro Forma in Assessing Morbidly Adherent Placenta With Correlation to Intra-operative Findings

Diagnostic Accuracy of a Specialized Pro Forma in Assessing Morbidly Adherent Placenta With Correlation to Intra-operative Findings

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04938050
Enrollment
21
Registered
2021-06-24
Start date
2021-06-18
Completion date
2023-02-28
Last updated
2022-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Morbidly Adherent Placenta

Brief summary

This study objective is to assess the accuracy of a specialized pro forma in suggesting the probability of Morbidly Adherent Placenta, its extent and its correlation with intraoperative findings.

Interventions

DIAGNOSTIC_TESTUltrasound

Ultrasound evaluation, with grayscale and color Doppler imaging.

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
28 Years to 42 Years
Healthy volunteers
No

Inclusion criteria

* Age group 28:42 years. * Pregnant women in their late third trimester (34 0/7 weeks: 37 0/7 weeks). * With a single living fetus in the current pregnancy. * A previous delivery by at least 1 cesarean section or history of uterine surgery including (surgical evacuation, myomectomy or endometrium ablation) * Having an anterior placenta previa or anterior low-lying placenta by ultrasound assessment.

Exclusion criteria

* Cases with a non-previa placenta, posterior low lying placenta or posterior previa placenta. * Maternal chronic medical disorders( diabetes mellitus, hypertension) * Patients presented with severe attack of bleeding. * Patients presented with rupture of membrane. * Emergency delivery regardless the cause.

Design outcomes

Primary

MeasureTime frame
Clinical significance of ultrasound signs in morbidly adherent placenta(most sensitive US sign)June 2021- July 2022
Accuracy of our specialized pro forma in assessing extent of morbidly adherent placenta(focal , diffuse)June 2021- July 2022
Accuracy of our specialized pro forma in assessing depth of invasion of placenta accreta spectrum (accrete, increta and percreta)June 2021- July 2022

Secondary

MeasureTime frame
1- Correlation between US signs and intraoperative findings including morbidity and mortalityJune 2021- July 2022

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026